Abstract:To utilize metabolomics in conjunction with RNA sequencing to identify biomarkers in the blood of sepsis patients and discover novel targets for diagnosing and treating sepsis. In January 2019 and December 2020, blood samples were collected from a cohort of 16 patients diagnosed with sepsis and 11 patients diagnosed with systemic inflammatory response syndrome (SIRS). Non-targeted metabolomics analysis was conducted using liquid chromatography coupled with mass spectrometry (LC–MS/MS technology), while gene sequencing was performed using RNA sequencing. Afterward, the metabolite data and sequencing data underwent quality control and difference analysis, with a fold change (FC) greater than or equal to 2 and a false discovery rate (FDR) less than 0.05.Co-analysis was then performed to identify differential factors with consistent expression trends based on the metabolic pathway context; KEGG enrichment analysis was performed on the crossover factors, and Meta-analysis of the targets was performed at the transcriptome level using the public dataset. In the end, a total of five samples of single nucleated cells from peripheral blood (two normal controls, one with systemic inflammatory response syndrome, and two with sepsis) were collected and examined to determine the cellular location of the essential genes using 10× single cell RNA sequencing (scRNA-seq). A total of 485 genes and 1083 metabolites were found to be differentially expressed in the sepsis group compared to the SIRS group. Among these, 40 genes were found to be differentially expressed in both the metabolome and transcriptome. Functional enrichment analysis revealed that these genes were primarily involved in biological processes related to inflammatory response, immune regulation, and amino acid metabolism. Furthermore, a meta-analysis identified four genes, namely ITGAM, CD44, C3AR1, and IL2RG, which were highly expressed in the sepsis group compared to the normal group ( P < 0.05). Additionally, scRNA-seq analysis revealed that the core genes ITGAM and C3AR1 were predominantly localized within the macrophage lineage. The primary genes ITGAM and C3AR1 exhibit predominant expression in macrophages, which play a significant role in inflammatory and immune responses. Moreover, these genes show elevated expression levels in the plasma of individuals with sepsis, indicating their potential as valuable subjects for further research in sepsis.

Immunometabolic signatures predict risk of progression to sepsis in COVID-19

Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia

Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation

IL-6, IL-10, sFas, granulysin and indicators of intestinal permeability as early biomarkers for a fatal outcome in COVID-19

Serum metabolite profiling reveals metabolic characteristics of sepsis patients using LC/MS-based metabolic profiles: a cross-sectional study

The Serum Metabolome of COVID-19 Patients is Distinctive and Predictive

Metabolic predictors of COVID-19 mortality and severity: a survival analysis

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19

Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

Metabolomic profiling of COVID-19 using serum and urine samples in intensive care and medical ward cohorts

Landscape of Metabolic Fingerprinting for Diagnosis and Risk Stratification of Sepsis

Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction

Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis

Biomarkers and prognostic models for severe COVID-19 in comparison with other etiologies of sepsis

The Landscape of Featured Metabolism-Related Genes and Imbalanced Immune Cell Subsets in Sepsis

Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study

Biomarkers and sepsis severity as predictors of mechanical ventilation and mortality in COVID-19

Parallel Dysregulated Immune Response in Severe Forms of COVID-19 and Bacterial Sepsis via Single-Cell Transcriptome Sequencing

Combining Semi-Targeted Metabolomics and Machine Learning to Identify Metabolic Alterations in the Serum and Urine of Hospitalized Patients with COVID-19

Discrimination of Sepsis Stage Metabolic Profiles with an LC/MS-MS-based Metabolomics Approach.

Metabolic and immune markers for precise monitoring of COVID-19 severity and treatment